7.19
price down icon4.26%   -0.32
after-market After Hours: 7.19
loading
Evolus Inc stock is traded at $7.19, with a volume of 707.87K. It is down -4.26% in the last 24 hours and up +12.34% over the past month. Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.
See More
Previous Close:
$7.51
Open:
$7.53
24h Volume:
707.87K
Relative Volume:
0.54
Market Cap:
$465.09M
Revenue:
$202.09M
Net Income/Loss:
$-61.69M
P/E Ratio:
-6.6574
EPS:
-1.08
Net Cash Flow:
$-35.64M
1W Performance:
-6.14%
1M Performance:
+12.34%
6M Performance:
-46.42%
1Y Performance:
-56.32%
1-Day Range:
Value
$7.19
$7.58
1-Week Range:
Value
$7.19
$7.70
52-Week Range:
Value
$5.71
$17.82

Evolus Inc Stock (EOLS) Company Profile

Name
Name
Evolus Inc
Name
Phone
(949) 284-4555
Name
Address
520 NEWPORT CENTER DRIVE, NEWPORT BEACH
Name
Employee
394
Name
Next Earnings Date
2025-03-04
Name
Latest SEC Filings
Name
EOLS's Discussions on Twitter

Compare EOLS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
EOLS
Evolus Inc
7.19 475.44M 202.09M -61.69M -35.64M -1.08
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
148.20 66.22B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.10 48.29B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.81 43.99B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
19.93 22.45B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
405.02 17.93B 2.99B 1.21B 1.13B 25.06

Evolus Inc Stock (EOLS) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-06-25 Downgrade Needham Buy → Hold
Apr-17-25 Initiated BTIG Research Buy
Jan-29-24 Upgrade Barclays Equal Weight → Overweight
Jun-23-22 Initiated Needham Buy
May-12-22 Upgrade Barclays Underweight → Equal Weight
Jan-20-22 Upgrade Truist Hold → Buy
May-06-21 Upgrade Mizuho Neutral → Buy
Apr-08-21 Reiterated H.C. Wainwright Buy
Feb-24-21 Downgrade Truist Buy → Hold
Jul-07-20 Downgrade Mizuho Buy → Neutral
Feb-06-20 Resumed Mizuho Buy
Nov-26-19 Initiated SVB Leerink Outperform
Sep-05-19 Resumed Mizuho Buy
Jun-28-19 Initiated Wells Fargo Market Perform
Jun-11-19 Initiated Barclays Underweight
Mar-20-19 Initiated SunTrust Buy
Feb-14-19 Initiated H.C. Wainwright Buy
Jan-29-19 Initiated Stifel Buy
View All

Evolus Inc Stock (EOLS) Latest News

pulisher
Sep 12, 2025

Evolus announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener

Sep 12, 2025
pulisher
Sep 12, 2025

Evolus Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Sep 12, 2025
pulisher
Sep 11, 2025

Adage Capital Partners GP L.L.C. Buys New Position in Evolus, Inc. $EOLS - MarketBeat

Sep 11, 2025
pulisher
Sep 11, 2025

Alyeska Investment Group L.P. Reduces Holdings in Evolus, Inc. $EOLS - MarketBeat

Sep 11, 2025
pulisher
Sep 11, 2025

Short Interest in Evolus, Inc. (NASDAQ:EOLS) Decreases By 20.8% - MarketBeat

Sep 11, 2025
pulisher
Sep 11, 2025

Zimmer Partners LP Increases Stake in Evolus, Inc. $EOLS - MarketBeat

Sep 11, 2025
pulisher
Sep 10, 2025

Evolus' (EOLS) "Buy" Rating Reiterated at BTIG Research - MarketBeat

Sep 10, 2025
pulisher
Sep 09, 2025

Evolus Announces the Appointment of Tatjana Mitchell as Chief Financial Officer - BioSpace

Sep 09, 2025
pulisher
Sep 09, 2025

Boothbay Fund Management LLC Sells 146,543 Shares of Evolus, Inc. $EOLS - MarketBeat

Sep 09, 2025
pulisher
Sep 08, 2025

Even With A 30% Surge, Cautious Investors Are Not Rewarding Evolus, Inc.'s (NASDAQ:EOLS) Performance Completely - 富途牛牛

Sep 08, 2025
pulisher
Sep 08, 2025

Evolus Appoints Tatjana Mitchell as New CFO - TipRanks

Sep 08, 2025
pulisher
Sep 08, 2025

Evolus Appoints Tatjana Mitchell as CFO - Orange County Business Journal

Sep 08, 2025
pulisher
Sep 08, 2025

Evolus appoints Tatjana Mitchell as CFO - TipRanks

Sep 08, 2025
pulisher
Sep 08, 2025

Evolus Announces the Appointment of Tatjana Mitchell as Chief Fi - GuruFocus

Sep 08, 2025
pulisher
Sep 08, 2025

Evolus announces the appointment of Tatjana Mitchell as chief financial officer - MarketScreener

Sep 08, 2025
pulisher
Sep 08, 2025

Chart Analysts Warn of Resistance Near Evolus Inc. Price2025 Market Trends & Fast Momentum Entry Tips - beatles.ru

Sep 08, 2025
pulisher
Sep 08, 2025

Panagora Asset Management Inc. Invests $2.94 Million in Evolus, Inc. $EOLS - MarketBeat

Sep 08, 2025
pulisher
Sep 07, 2025

Walleye Capital LLC Has $475,000 Stock Position in Evolus, Inc. $EOLS - MarketBeat

Sep 07, 2025
pulisher
Sep 06, 2025

Evolus, Inc. $EOLS Shares Sold by AWH Capital L.P. - MarketBeat

Sep 06, 2025
pulisher
Sep 06, 2025

Trendlines Suggest Evolus Inc. May Bottom Out SoonQuarterly Trade Summary & Risk Managed Investment Strategies - beatles.ru

Sep 06, 2025
pulisher
Sep 06, 2025

How does Evolus Inc. correlate with NasdaqJuly 2025 Short Interest & Low Drawdown Trading Techniques - خودرو بانک

Sep 06, 2025
pulisher
Sep 06, 2025

Is Evolus Inc. stock trending bullishRecession Risk & Weekly Hot Stock Watchlists - خودرو بانک

Sep 06, 2025
pulisher
Sep 06, 2025

Trexquant Investment LP Buys 201,438 Shares of Evolus, Inc. $EOLS - MarketBeat

Sep 06, 2025
pulisher
Sep 05, 2025

Is Evolus Inc. stock reversal real or fakeMarket Growth Summary & Stock Portfolio Risk Management - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

How institutional ownership impacts Evolus Inc. stock2025 Breakouts & Breakdowns & Safe Investment Capital Preservation Plans - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Automated trading signals detected on Evolus Inc.Quarterly Earnings Report & Risk Managed Investment Entry Signals - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Pattern recognition hints at Evolus Inc. upsideWeekly Gains Report & Accurate Intraday Trade Tips - Newser

Sep 05, 2025
pulisher
Sep 04, 2025

What is Evolus Inc. s 5 year growth outlookJuly 2025 Sentiment & Technical Pattern Based Buy Signals - خودرو بانک

Sep 04, 2025
pulisher
Sep 04, 2025

Has Evolus Inc. found a price floorProduct Launch & Real-Time Stock Movement Alerts - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Price action breakdown for Evolus Inc.Quarterly Trade Summary & Advanced Swing Trade Entry Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Evolus Inc. a speculative investmentQuarterly Market Summary & Long-Term Growth Plans - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

Has Evolus Inc. formed a bullish divergenceJuly 2025 Closing Moves & Weekly Market Pulse Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Chart based analysis of Evolus Inc. trendsWeekly Loss Report & Reliable Price Breakout Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Tools to monitor Evolus Inc. recovery probabilityGlobal Markets & Fast Gain Stock Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Jump Financial LLC Grows Position in Evolus, Inc. $EOLS - MarketBeat

Sep 03, 2025
pulisher
Sep 03, 2025

Using Bollinger Bands to evaluate Evolus Inc.2025 Top Gainers & Verified Momentum Stock Alerts - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

How moving averages guide Evolus Inc. tradingGap Down & Comprehensive Market Scan Reports - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Will breakout in Evolus Inc. lead to full recovery2025 Big Picture & Real-Time Price Movement Reports - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is a relief rally coming for Evolus Inc. holders2025 Trade Ideas & Real-Time Stock Price Movement Reports - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What is Evolus Inc. s 5 year growth outlook getLinesFromResByArray error: size == 0 - 머스트 뉴스

Sep 02, 2025
pulisher
Sep 02, 2025

Quantitative breakdown of Evolus Inc. recent moveFed Meeting & Target Return Focused Stock Picks - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Tri Locum Partners LP Sells 420,772 Shares of Evolus, Inc. $EOLS - MarketBeat

Sep 02, 2025
pulisher
Sep 01, 2025

Can trapped investors hope for a rebound in Evolus Inc.Market Performance Recap & Fast Gaining Stock Strategy Reports - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Drawdown in Evolus Inc. May Be Nearing End getLinesFromResByArray error: size == 0 - 강소기업뉴스

Aug 31, 2025
pulisher
Aug 31, 2025

Trendlines Suggest Evolus Inc. May Bottom Out Soon getLinesFromResByArray error: size == 0 - classian.co.kr

Aug 31, 2025

Evolus Inc Stock (EOLS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$26.97
price down icon 2.67%
$18.53
price down icon 1.33%
$9.96
price down icon 2.06%
drug_manufacturers_specialty_generic RDY
$14.66
price down icon 0.48%
$141.87
price down icon 1.20%
$405.02
price up icon 0.04%
Cap:     |  Volume (24h):